Amy S. Broidrick serves as Executive at Qualigen Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Amy S. Broidrick has executed 2 insider transactions totaling $27.7K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 14, 2022 involved purchasing 30,000 shares valued at $18.6K.
Amy S. Broidrick currently holds 34,500 shares of Qualigen Therapeutics, Inc. (QLGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Amy S. Broidrick has been a net buyer of QLGN stock. They have purchased $27.7K and sold $0 worth of shares.
Amy S. Broidrick's most recent insider trade was on Jun 14, 2022, when they purchased 30,000 shares at $0.62 per share.
Get notified when new Form 4 filings are submitted
| $2.03 |
| Discretionary |